Australians deserve fast access to the latest medicines, vaccines and treatments

28 January 2022 - Medicines Australia recommends the Australian Government delivers a plan to shorten the time that patients wait ...

Read more →

Pfizer's COVID-19 vaccine (Comirnaty) provisionally approved for use as a booster in individuals aged 16-17 years old

28 January 2022 - The Therapeutic Goods Administration has provisionally approved the Pfizer COVID-19 vaccine, Comirnaty for use as a ...

Read more →

Moderna aims to deliver Omicron COVID-19 vaccine by September

27 January 2022 - A COVID-19 booster shot, targeted specifically at the Omicron variant, is expected to be delivered by ...

Read more →

COVID-19 vaccine weekly safety report (27 January 2022)

27 January 2022 - To 23 January 2022, the TGA has received 431 reports which have been assessed as likely to ...

Read more →

Pfizer pushes to intervene in lawsuit seeking COVID vaccine information from FDA

27 January 2022 - Pfizer wants to intervene in a Texas federal lawsuit seeking information from the U.S. FDA used ...

Read more →

TGA approves MSD's Vaxneuvance

24 January 2022 - Vaxneuvance (pneumococcal 15 valent conjugate vaccine (CRM197 protein)) was approved on 17 January 2022 for active ...

Read more →

Novavax COVID-19 vaccine to be available in coming weeks

24 January 2022 - Australians aged 18+ will now have access to a fourth COVID-19 vaccine, Nuvaxovid (Novavax) in coming weeks, ...

Read more →

ATAGI statement on the use of Novavax COVID-19 vaccine (Nuvaxovid)

24 January 2022 - ATAGI recommends that Novavax COVID-19 vaccine can be used for the primary course of COVID-19 vaccination ...

Read more →

COVID-19 vaccines and treatments: we must have raw data, now

19 January 2022 - Data should be fully and immediately available for public scrutiny ...

Read more →

International regulators’ recommendations on COVID-19 vaccines and the Omicron variant

21 January 2022 - International regulators have published a report today highlighting their discussions on the effectiveness of current vaccines against ...

Read more →

COVID-19 vaccine weekly safety report (20 January 2022)

20 January 2022 - To 16 January 2022, the TGA has received 428 reports which have been assessed as likely to ...

Read more →

Statement on the arrival of the Novavax vaccine and COVID-19 pills

20 January 2022 - Medicines Australia welcomes the TGA’s provisional approval for the Novavax COVID-19 vaccine and the provisional approval ...

Read more →

TGA provisionally approves Novavax (Biocelect) COVID-19 vaccine Nuvaxovid

20 January 2022 - The Therapeutic Goods Administration has granted provisional approval to Biocelect (on behalf of Novavax) for its ...

Read more →

Lieutenant General John Frewen says he expects TGA approval of Novavax vaccine is 'imminent'

19 January 2022 - The head of Australia's vaccine rollout expects one to two per cent of Australians who remain unvaccinated ...

Read more →

COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy

18 January 2022 - Vaccination remains a major pillar of the response to COVID-19, particularly as variants of the virus continue ...

Read more →